| |
Latest 10 SEC filings (by transaction date) for APLS within the last 6 months | |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Sep 30/24 | Sep 27/24 | Watson David O. | Direct Ownership | Common Stock | G - Gift | 10,569 | |
Sep 30/24 | Sep 27/24 | Watson David O. | Indirect Ownership | Common Stock | G - Gift | -10,569 | |
Sep 24/24 | Sep 23/24 | Dunlop A. Sinclair | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -4,600 | |
Sep 24/24 | Sep 23/24 | Dunlop A. Sinclair | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 4,600 | $13.19 |
Sep 17/24 | Sep 16/24 | Chopas James George | Direct Ownership | Common Stock | S - Open market or private sale | -192 | $36.21 |
Sep 17/24 | Sep 16/24 | Dunlop A. Sinclair | Indirect Ownership | Common Stock | S - Open market or private sale | -7,524 | $36.79 |
Sep 17/24 | Sep 16/24 | Dunlop A. Sinclair | Indirect Ownership | Common Stock | S - Open market or private sale | -29,476 | $36.09 |
Sep 4/24 | Sep 3/24 | Chopas James George | Direct Ownership | Common Stock | S - Open market or private sale | -550 | $39.49 |
Aug 13/24 | Aug 12/24 | DeLong Mark Jeffrey | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -5,201 | |
Aug 13/24 | Aug 12/24 | DeLong Mark Jeffrey | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 5,201 | $13.85 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for APLS within the last 6 months | |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Sep 30/24 | Sep 27/24 | Watson David O. | Direct Ownership | Common Stock | G - Gift | 10,569 | |
Sep 30/24 | Sep 27/24 | Watson David O. | Indirect Ownership | Common Stock | G - Gift | -10,569 | |
Sep 24/24 | Sep 23/24 | Dunlop A. Sinclair | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -4,600 | |
Sep 24/24 | Sep 23/24 | Dunlop A. Sinclair | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 4,600 | $13.19 |
Sep 17/24 | Sep 16/24 | Chopas James George | Direct Ownership | Common Stock | S - Open market or private sale | -192 | $36.21 |
Sep 17/24 | Sep 16/24 | Dunlop A. Sinclair | Indirect Ownership | Common Stock | S - Open market or private sale | -7,524 | $36.79 |
Sep 17/24 | Sep 16/24 | Dunlop A. Sinclair | Indirect Ownership | Common Stock | S - Open market or private sale | -29,476 | $36.09 |
Sep 4/24 | Sep 3/24 | Chopas James George | Direct Ownership | Common Stock | S - Open market or private sale | -550 | $39.49 |
Aug 13/24 | Aug 12/24 | DeLong Mark Jeffrey | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -5,201 | |
Aug 13/24 | Aug 12/24 | DeLong Mark Jeffrey | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 5,201 | $13.85 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Avidity Biosciences (OQ:RNA) |
Intra-Cellular Therapies (OQ:ITCI) |
ADMA Biologics (OQ:ADMA) |